Efficacy of tenofovir and efavirenz in combination with lamivudine or emtricitabine in antiretroviral-naive patients in Europe

J. E. Swartz; L. Vandekerckhove; H. Ammerlaan; A. C. De Vries; J. Begovac; W. F.W. Bierman; C. A.B. Boucher; M. E. Van Der Ende; Z. Grossman; R. Kaiser; I. Levy; T. Mudrikova; R. Paredes; D. Perez-Bercoff; M. Pronk; C. Richter; J. C. Schmit; J. Vercauteren; M. Zazzi; S. Židovec Lepej; Andrea De Luca; A. M.J. Wensing

doi:10.1093/jac/dkv033

Efficacy of tenofovir and efavirenz in combination with lamivudine or emtricitabine in antiretroviral-naive patients in Europe

J. E. Swartz, L. Vandekerckhove, H. Ammerlaan, A. C. De Vries, J. Begovac, W. F.W. Bierman, C. A.B. Boucher, M. E. Van Der Ende, Z. Grossman, R. Kaiser, I. Levy, T. Mudrikova, R. Paredes, D. Perez-Bercoff, M. Pronk, C. Richter, J. C. Schmit, J. Vercauteren, M. Zazzi, S. Židovec LepejAndrea De Luca, A. M.J. Wensing

Università Cattolica del Sacro Cuore

Risultato della ricerca: Contributo in rivista › Articolo

9 Citazioni (Scopus)

Abstract

The combination of tenofovir and efavirenz with either lamivudine or emtricitabine (TELE) has proved to be highly effective in clinical trials for first-line treatment of HIV-1 infection. However, limited data are available on its efficacy in routine clinical practice.

Lingua originale	Inglese
pagine (da-a)	1850-1857
Numero di pagine	8
Rivista	Journal of Antimicrobial Chemotherapy
Volume	70
DOI	https://doi.org/10.1093/jac/dkv033
Stato di pubblicazione	Pubblicato - 2015

Keywords

HIV-1
co-formulation
first-line antiretroviral therapy

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.1093/jac/dkv033

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

Swartz, J. E., Vandekerckhove, L., Ammerlaan, H., De Vries, A. C., Begovac, J., Bierman, W. F. W., Boucher, C. A. B., Van Der Ende, M. E., Grossman, Z., Kaiser, R., Levy, I., Mudrikova, T., Paredes, R., Perez-Bercoff, D., Pronk, M., Richter, C., Schmit, J. C., Vercauteren, J., Zazzi, M., ... Wensing, A. M. J. (2015). Efficacy of tenofovir and efavirenz in combination with lamivudine or emtricitabine in antiretroviral-naive patients in Europe. Journal of Antimicrobial Chemotherapy, 70, 1850-1857. https://doi.org/10.1093/jac/dkv033

@article{098b660ce01345ca81d8043f13fcf603,

title = "Efficacy of tenofovir and efavirenz in combination with lamivudine or emtricitabine in antiretroviral-naive patients in Europe",

abstract = "The combination of tenofovir and efavirenz with either lamivudine or emtricitabine (TELE) has proved to be highly effective in clinical trials for first-line treatment of HIV-1 infection. However, limited data are available on its efficacy in routine clinical practice.",

keywords = "HIV-1, co-formulation, first-line antiretroviral therapy, HIV-1, co-formulation, first-line antiretroviral therapy",

author = "Swartz, \{J. E.\} and L. Vandekerckhove and H. Ammerlaan and \{De Vries\}, \{A. C.\} and J. Begovac and Bierman, \{W. F.W.\} and Boucher, \{C. A.B.\} and \{Van Der Ende\}, \{M. E.\} and Z. Grossman and R. Kaiser and I. Levy and T. Mudrikova and R. Paredes and D. Perez-Bercoff and M. Pronk and C. Richter and Schmit, \{J. C.\} and J. Vercauteren and M. Zazzi and \{{\v Z}idovec Lepej\}, S. and \{De Luca\}, Andrea and Wensing, \{A. M.J.\}",

year = "2015",

doi = "10.1093/jac/dkv033",

language = "English",

volume = "70",

pages = "1850--1857",

journal = "Journal of Antimicrobial Chemotherapy",

issn = "0305-7453",

publisher = "Oxford University Press",

}

Swartz, JE, Vandekerckhove, L, Ammerlaan, H, De Vries, AC, Begovac, J, Bierman, WFW, Boucher, CAB, Van Der Ende, ME, Grossman, Z, Kaiser, R, Levy, I, Mudrikova, T, Paredes, R, Perez-Bercoff, D, Pronk, M, Richter, C, Schmit, JC, Vercauteren, J, Zazzi, M, Židovec Lepej, S, De Luca, A & Wensing, AMJ 2015, 'Efficacy of tenofovir and efavirenz in combination with lamivudine or emtricitabine in antiretroviral-naive patients in Europe', Journal of Antimicrobial Chemotherapy, vol. 70, pagg. 1850-1857. https://doi.org/10.1093/jac/dkv033

TY - JOUR

T1 - Efficacy of tenofovir and efavirenz in combination with lamivudine or emtricitabine in antiretroviral-naive patients in Europe

AU - Swartz, J. E.

AU - Vandekerckhove, L.

AU - Ammerlaan, H.

AU - De Vries, A. C.

AU - Begovac, J.

AU - Bierman, W. F.W.

AU - Boucher, C. A.B.

AU - Van Der Ende, M. E.

AU - Grossman, Z.

AU - Kaiser, R.

AU - Levy, I.

AU - Mudrikova, T.

AU - Paredes, R.

AU - Perez-Bercoff, D.

AU - Pronk, M.

AU - Richter, C.

AU - Schmit, J. C.

AU - Vercauteren, J.

AU - Zazzi, M.

AU - Židovec Lepej, S.

AU - De Luca, Andrea

AU - Wensing, A. M.J.

PY - 2015

Y1 - 2015

N2 - The combination of tenofovir and efavirenz with either lamivudine or emtricitabine (TELE) has proved to be highly effective in clinical trials for first-line treatment of HIV-1 infection. However, limited data are available on its efficacy in routine clinical practice.

AB - The combination of tenofovir and efavirenz with either lamivudine or emtricitabine (TELE) has proved to be highly effective in clinical trials for first-line treatment of HIV-1 infection. However, limited data are available on its efficacy in routine clinical practice.

KW - HIV-1

KW - co-formulation

KW - first-line antiretroviral therapy

KW - HIV-1

KW - co-formulation

KW - first-line antiretroviral therapy

UR - http://hdl.handle.net/10807/68433

U2 - 10.1093/jac/dkv033

DO - 10.1093/jac/dkv033

M3 - Article

SN - 0305-7453

VL - 70

SP - 1850

EP - 1857

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

ER -

Efficacy of tenofovir and efavirenz in combination with lamivudine or emtricitabine in antiretroviral-naive patients in Europe

Abstract

Keywords

OSS delle Nazioni Unite

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo